Wordt geladen...
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2022-04-01
|
| Reeks: | International Journal of Molecular Sciences |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1422-0067/23/9/5009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|